Cassava sciences to present at the 2023 h.c. wainwright investor conference

Austin, texas, april 26, 2023 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, today announced that remi barbier, president & chief executive officer, has been invited to present at the 2023 h.c. wainwright bioconnect investor conference in new york. in addition, management will be available for one-on-one meetings with institutional investors who are registered to attend this conference.
SAVA Ratings Summary
SAVA Quant Ranking